Showing results (1-10 of 54) with videos related to
Sort By:
Pageof 6
Handbook of Experimental Pharmacology|April 13, 2011
AMP-activated protein kinase and metabolic controlBenoit Viollet, Fabrizio AndreelliJournal of Diabetes Research|July 7, 2016
Increasing GLP-1 Circulating Levels by Bariatric Surgery or by GLP-1 Receptor Agonists Therapy: Why Are the Clinical Consequences so Different?Chloé Amouyal, Fabrizio AndreelliDiabetes, Metabolic Syndrome and Obesity : Targets and Therapy|November 6, 2019
Dual GIP-GLP1-Receptor Agonists In The Treatment Of Type 2 Diabetes: A Short Review On Emerging Data And Therapeutic PotentialMarie Bastin, Fabrizio AndreelliCurrent Opinion in Clinical Nutrition and Metabolic Care|May 29, 2009
Intestinal gluconeogenesis: key signal of central control of energy and glucose homeostasisGilles Mithieux, Fabrizio Andreelli, Christophe MagnanCurrent Opinion in Clinical Nutrition and Metabolic Care|February 16, 2006
Molecular aspects of insulin therapy in critically ill patientsFabrizio Andreelli, Delphine Jacquier, Stéphanie TroyMedecine Sciences : M/S|February 24, 2026
[Cross-regulation between olfaction and energy homeostasis in obesity and type 2 diabetes: from mouse models to humans]Mireia Montaner, Fabrizio Andreelli, Christophe Magnan, et al.Medecine Sciences : M/S|December 10, 2024
[From the discovery of incretin hormones to GIP / GLP-1 / glucagon double and triple agonists]Franck Phan, Romane Bertrand, Chloé Amouyal, et al.Presse Medicale (Paris, France : 1983)|May 3, 2008
[Role of intestinal flora in insulin resistance and obesity]Amal Yazigi, Bénédicte Gaborit, Juan Patricio Nogueira, et al.Clinical Science (London, England : 1979)|November 29, 2011
Cellular and molecular mechanisms of metformin: an overviewBenoit Viollet, Bruno Guigas, Nieves Sanz Garcia, et al.The Biochemical Journal|February 28, 2007
AMP-activated protein kinase-independent inhibition of hepatic mitochondrial oxidative phosphorylation by AICA ribosideBruno Guigas, Nellie Taleux, Marc Foretz, et al.Pageof 6